Securities code: Maccura Biotechnology Co.Ltd(300463) securities abbreviation: Maccura Biotechnology Co.Ltd(300463) Announcement No.: 2022019
Maccura Biotechnology Co.Ltd(300463)
Announcement on changing the registered capital and amending the articles of Association
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete without false records, misleading statements or major omissions.
The following proposal on Amending the articles of association of the company (hereinafter referred to as the “amendment to the articles of association”) was held on March 3, 2023, and the following amendment to the articles of association was adopted
According to the reply on Approving the registration of Maccura Biotechnology Co.Ltd(300463) Co., Ltd. to issue shares to specific objects (zjxk [2021] No. 412) issued by China Securities Regulatory Commission (hereinafter referred to as “CSRC”), the company issued 56 million RMB common shares (A shares) to 17 specific objects, The new shares were listed on Shenzhen Stock Exchange on February 18, 2022. After the registration of the shares corresponding to this issuance, the total share capital of the company increased from 556469590 shares to 612469590 shares, and the registered capital of the company increased from 55646959000 yuan to 61246959000 yuan.
The corresponding provisions of the articles of association are amended as follows:
Original clause revised clause
Article 6 the registered capital of the company is RMB 556469590. Article 6 the registered capital of the company is RMB 612469590. Yuan.
Article 19 the total number of shares of the company is 556469590, and the total number of shares of the company is 612469590, all of which are ordinary shares. Common stock.
2、 Deliberations of the board of directors
The second meeting of the Fifth Board of directors of the company deliberated and approved the proposal on changing the registered capital and amending the articles of association. The above proposal must be submitted to the second extraordinary general meeting of shareholders of the company in 2022 for deliberation.
Securities code: Maccura Biotechnology Co.Ltd(300463) securities abbreviation: Maccura Biotechnology Co.Ltd(300463) Announcement No.: 2022019
3、 Documents for future reference
Resolution of the second meeting of the 5th board of directors
It is hereby announced.
Maccura Biotechnology Co.Ltd(300463) board of directors March 3, 2002
